Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sales & Earnings In Brief

This article was originally published in The Tan Sheet

Executive Summary

Prestige Brands Q4: The OTC marketer will leverage the success of last season's Chloraseptic liquid center lozenge with the upcoming introduction of a maximum strength lozenge as well as a spray form, according to a May 15 release. In the January-March period, the Irvington, N.Y.-based firm's OTC healthcare business advanced 7 percent to $46.2 million, benefiting from growth of Murine Earigate as well as double-digit growth of Clear Eyes on the launch of Maximum Redness, Prestige Brands reports May 15. Net sales rose 3 percent to $80.4 million and net income grew 24 percent to $10.4 million, the firm notes. For its fiscal year 2008, Prestige Brands' net revenues grew 3 percent to $326.6 million, though net income fell 6 percent to $33.9 million due to a favorable tax benefit in 2007, the firm notes...
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS101676

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel